Acceptability and satisfaction with a telecarer approach to the management of type 2 diabetes

被引:32
|
作者
Long, AF
Taylor, J
Gambling, T
Mason, JM
Young, RJ
机构
[1] Univ Salford, Hlth Care Practice R&D Unit, Salford M6 6PU, Lancs, England
[2] Cardiff Univ, Sch Hlth Care Studies, Cardiff, S Glam, Wales
[3] Hope Hosp, Salford M6 8HD, Lancs, England
[4] Univ Durham, Sch Hlth, Stockton On Tees, England
关键词
D O I
10.2337/diacare.28.2.283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To examine patients views of the acceptability of and satisfaction with telephone care center support provided to improve blood glucose control in type 2 diabetes. RESEARCH DESIGN AND METHODS - The Pro-Active Call-Center Treatment Support (PACCTS) Trial randomized patients from 47 general practices in a deprived urban area in 0 northwest England to usual care or to proactive call center support in addition to usual care. Satisfaction with care was assessed in all 591 patients at baseline and the end of the study using the Diabetes Satisfaction and Treatment Questionnaire (DTSQ). Acceptability was assessed in 394 intervention patients after at least three proactive calls from the call center and at the end of the trial. A purposive sample of 25 patients took part in in-depth semistructured interviews. RESULTS - The response rates to the questionnaires were 79% (DTSQ) and 65% (acceptability). Persons receiving the intervention continued to report high levels of satisfaction with their treatment (95% CI 32.3-33.2 at I year), and >90% strongly agreed or agreed that the telecarer approach was acceptable. Qualitative comments pointed to the importance of a personalized service; increased feelings of well-being, including confidence and self-control: help with problem-solving; and patients developing rapport and a strong bond with the telecarers. CONCLUSIONS - A personalized PACCTS approach is acceptable to patients. A Service giving priority to the interpersonal dimension leads to increased commitment from patients to improve long-term glycemic control. Diabetes Care 28:283-289. 2005.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [41] Efficacy and Acceptability of My Care Hub Mobile App to Support Self-Management in Australians with Type 1 or Type 2 Diabetes
    Adu, Mary D.
    Malabu, Usman H.
    Malau-Aduli, Aduli E. O.
    Drovandi, Aaron
    Malau-Aduli, Bunmi S.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (07)
  • [42] Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes
    Yardley, Jane E.
    Colberg, Sheri R.
    CURRENT SPORTS MEDICINE REPORTS, 2017, 16 (01) : 38 - 44
  • [43] Inpatient Management of Type 2 Diabetes
    Warnock, Shane
    Latifi, Niloofar
    JAMA INTERNAL MEDICINE, 2022, 182 (05) : 543 - 544
  • [44] DIETARY MANAGEMENT OF TYPE 2 DIABETES
    Aldhban, Abdullah Yahya
    Abukhodair, Abdulaziz Osama
    Fakeih, Elaf Mohammed Taha Ibraheem
    ALdakhlan, Hussain Ali
    Alhassan, Mohammed Yousef Hassan
    Heameed, Roaa Ali
    Jumah, Suad Ahmed
    Alaish, Mohammed Hashim A.
    Alqahtani, Saad Saeed Mohammed
    Hisan, Fatimah Mohammed
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 13571 - 13577
  • [45] DIETARY MANAGEMENT OF TYPE 2 DIABETES
    Aldhban, Abdullah Yahya
    Abukhodair, Abdulaziz Osama
    Fakeih, Elaf Mohammed Taha Ibraheem
    ALdakhlan, Hussain Ali
    Alhassan, Mohammed Yousef Hassan
    Heameed, Roaa Ali
    Jumah, Suad Ahmed
    Alaish, Mohammed Hashim A.
    Alqahtani, Saad Saeed Mohammed
    Hisan, Fatimah Mohammed
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 16467 - 16473
  • [46] Assessment of the management of type 2 diabetes
    Hanaire-Broutin, H
    Després, JP
    Dubois-Randé, JL
    Grimaldi, A
    PRESSE MEDICALE, 2004, 33 (16): : 1121 - 1123
  • [47] Pharmacologic management of type 2 diabetes
    不详
    CANADIAN PHARMACISTS JOURNAL, 2009, 142 : S19 - +
  • [48] Pharmacologic Management of Type 2 Diabetes
    Harper, William
    Clement, Maureen
    Goldenberg, Ronald
    Hanna, Amir
    Main, Andrea
    Retnakaran, Ravi
    Sherifali, Diana
    Woo, Vincent
    Yale, Jean-Francois
    CANADIAN JOURNAL OF DIABETES, 2013, 37 : S61 - S68
  • [49] Colesevelam for the management a of Type 2 diabetes
    Marrs, Joel C.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (02) : 187 - 194
  • [50] Overview of the management of Type 2 diabetes
    Standl, E
    DIABETES-METABOLISM REVIEWS, 1998, 14 : S13 - S17